•  
  •  
 

Lynchburg Journal of Medical Science

Lynchburg Journal of Medical Science

Specialty

Cardiology/Oncology

Advisor

Dr. Elyse Watkins

Abstract

Doxorubicin, one of the most commonly used anthracycline chemotherapy agents, is known in the oncology field for potential cardiotoxicity. The purpose of this article is to present a case of a breast cancer patient who was treated with an anthracycline chemotherapy agent and presented with newly diagnosed cardiomyopathy. The article will review the workup leading to the diagnosis of anthracycline cardiotoxicity, mechanisms of action, and proposed management.

Restricted

Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.

Off-campus users can also use 'Off-campus Download' button above for access.

Share

COinS